![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 35/34 | |
C12N 5/077 | |||
A61P 25/00 |
(11) | Number of the document | 2680864 |
(13) | Kind of document | T |
(96) | European patent application number | 12711003.9 |
Date of filing the European patent application | 2012-03-01 | |
(97) | Date of publication of the European application | 2014-01-08 |
(45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2012/050976 |
Date | 2012-03-01 |
(87) | Number | WO 2012/117373 |
Date | 2012-09-07 |
(30) | Number | Date | Country code |
201161448712 P | 2011-03-03 | US |
(72) |
OFFEN, Daniel, IL
DADON-NACHUM, Michal, IL
BEN-ZUR, Tali, IL
MELAMED, Eldad, IL
YAFFE, David, IL
|
(73) |
Ramot at Tel-Aviv University Ltd.,
P.O. Box 39296, 61392 Tel Aviv,
IL
Yeda Research and Development Co. Ltd., At the Weizmann Institute of Science P.O. Box 95, 76100 Rehovot, IL |
(54) | GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS |
GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS |